Skip to content

Building a Multidisciplinary Research Program to Address Hypertension Disparities: Exploring the Neurocognitive Mechanisms of a Self-Management Intervention for African American Women

Building a Multidisciplinary Research Program to Address Hypertension Disparities: Exploring the Neurocognitive Mechanisms of a Self-Management Intervention for African American Women

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04266704
Enrollment
50
Registered
2020-02-12
Start date
2023-06-13
Completion date
2025-04-25
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The goal of this project is to develop and pilot test a research protocol to assess the influence of a health information behavior enhanced intervention on self-management, blood pressure control, and brain activity in African American women with hypertension. This work will identify characteristics of African American women that are associated with improved self-management and decreased blood pressure, and subsequent reduction of risk of heart disease and premature death. The results of this project will have direct impact in informing interventions to improve blood pressure control, by advancing our knowledge of brain activity associated with behavior change in African American women with hypertension in the metro-Detroit area, and ultimately everywhere.

Interventions

BEHAVIORALSharing Intervention

intervention includes both analytic and socioemotional components related to self-management of hypertension and is specifically targeted to African American women. Along with providing education on lifestyle changes to lower blood pressure, DASH diet, exercise, and medication adherence (analytic components), the intervention is designed to promote social activities around blood pressure self-management, in particular, sharing blood pressure management information with peers (socioemotional components).

Sponsors

University of Michigan
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion criteria are (a) aged \>18, (b) clinically diagnosed with hypertension, and (c) right-handed (due to potential differences in brain morphology compared to left-handed individuals). \-

Design outcomes

Primary

MeasureTime frameDescription
Brain Activity6 monthsfMRI protocol - Each participant was presented the same conditions, in the same order . A fixed sequence design was used because the primary goal was to compare patterns of brain activity between participants. Means are estimated averages of each participant's response to video conditions.

Secondary

MeasureTime frameDescription
Systolic Blood Pressure6 monthsBlood pressure was measured using automated sphygmomanometer based on standardized protocols.
Diastolic Blood Pressure6 monthsBlood pressure was measured using automated sphygmomanometer based on standardized protocols.
PROMIS - Mental Health6 monthsHealth-related quality of life was measured with the PROMIS Global Scale. This 10-item measured the overall physical, mental, and social health of adults. Items range from (1 = never to 5 = always) on a Likert-type scale. Higher scores indicate better quality of life.
PROMIS - Physical Health6 monthsHealth-related quality of life was measured with the PROMIS Global Scale. This 10-item measured the overall physical, mental, and social health of adults. Items range from (1 = never to 5 = always) on a Likert-type scale. Higher scores indicate better quality of life.

Countries

United States

Baseline characteristics

Characteristic
Age, Continuous53.04 years
STANDARD_DEVIATION 7.6
Brain Activity0.09 Values reflect % change in BOLD response
STANDARD_DEVIATION 0.42
Diastolic Blood Pressure86.76 mm Hg
STANDARD_DEVIATION 9.21
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
25 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
PROMIS - Mental Health3.16 scores on a scale
STANDARD_DEVIATION 0.69
PROMIS - Physical Health3.18 scores on a scale
STANDARD_DEVIATION 0.48
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
25 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Sex: Female, Male
Female
25 Participants
Sex: Female, Male
Male
0 Participants
Systolic Blood Pressure132.56 mm Hg
STANDARD_DEVIATION 17.41

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026